Information on the target
3i Group plc has acquired a majority stake in Laboratoire Nutergia, a pioneering company in the field of micronutrition, which was founded in 1989 by the Lagarde family. Laboratoire Nutergia specializes in developing premium, science-backed health supplements aimed at enhancing overall wellness and addressing specific health needs through micronutrition.
This acquisition marks a significant milestone for Laboratoire Nutergia, as it will now benefit from the operational and financial support provided by 3i Group. This partnership is expected to facilitate the brand's growth trajectory and expand its market presence on a global scale.
Industry overview in the target’s specific country
The Alternative Medicine industry in France has been experiencing notable growth, driven by an increasing consumer shift towards holistic health solutions and natural remedies. This trend is largely influenced by a growing awareness of the potential side effects of conventional pharmaceuticals, prompting consumers to seek safer and more natural alternatives for their health concerns.
In recent years, the French government has also shown a supportive stance towards alternative medicine practices, integrating certain modalities into the national healthcare system. This has led to a rise in the legitimacy and acceptance of alternative therapies, including micronutrition, which focuses on the role of vitamins, minerals, and other nutrients in health maintenance and disease prevention.
Furthermore, the COVID-19 pandemic has accelerated the demand for preventive health measures, with consumers increasingly investing in supplements that bolster their immune systems and overall health. This has created a fertile environment for companies like Laboratoire Nutergia, which are well-positioned to meet the rising demand for high-quality alternative health products.
As the market continues to evolve, there is significant potential for innovation and expansion within the Alternative Medicine sector in France. Companie…